Guiyang Jiang

1.7k citations
78 papers · 1.3k indexed · h-index 21
Topics
Cancer-related gene regulation (23 papers)Wnt/β-catenin signaling in development and cancer (21 papers)Bladder and Urothelial Cancer Treatments (16 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Guiyang Jiang

77 papers receiving 1.3k citations

Peers

Guiyang Jiang
Comparison fields: 5 of 88
  • Molecular Biology 899
  • Cancer Research 324
  • Oncology 310
  • Pulmonary and Respiratory Medicine 261
  • Surgery 196
Replace Xuyong Lin with:
Xuyong Lin China
Fan Wu China
Chee Wai Chua Hong Kong
Daniel Wetterskog United Kingdom
Ciara Metcalfe United States
Zhiguo Chen China
Lauren Marquis United States
Soufiane Boumahdi United States
Jung Hwan Yoon South Korea
Juan Bayo Argentina
Guiyang Jiang relative to Xuyong Lin China Xuyong Lin's profile →
Citations per field
00.5×1.5×
Xuyong Lin · 1×
Citations per year

Countries citing papers authored by Guiyang Jiang

Since Specialization
Citations

This map shows the geographic impact of Guiyang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiyang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiyang Jiang more than expected).

Fields of papers citing papers by Guiyang Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiyang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiyang Jiang. The network helps show where Guiyang Jiang may publish in the future.

Co-authorship network of co-authors of Guiyang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guiyang Jiang. A scholar is included among the top collaborators of Guiyang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiyang Jiang. Guiyang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 9
4 8
5 6
6 12
7 22
8 41
9 19
10 3
11 55
12 16
13 12
14 28
15 24
16 19
17 14
18 25
19 6
20 16

About Guiyang Jiang

Guiyang Jiang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related gene regulation (23 papers), Wnt/β-catenin signaling in development and cancer (21 papers) and Bladder and Urothelial Cancer Treatments (16 papers). The work is most often cited by research in Cancer Research (324 citations), Molecular Biology (899 citations) and Oncology (310 citations). Guiyang Jiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiupeng Zhang, Enhua Wang, Yuan Miao, Xuyong Lin, Hiroshi Miyamoto, Chuifeng Fan, Taichi Mizushima, Hiroki Ide, Satoshi Inoue and Hong‐Tao Xu. Their work appears in journals such as PLoS ONE, Cancer Research and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026